News
Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate
AGC Biologics announced a new partnership with Allergy Therapeutics, the fully integrated specialty pharmaceutical company specializing in allergy vaccines. The CDMO has manufactured phase I clinical trial materials for Allergy Therapeutics’ novel virus-like particle (VLP)-based peanut allergy vaccine candidate...
News
Alcami Expands Biopharma Storage at Masy BioServices
Alcami announced plans to expand its biostorage footprint at Masy BioServices. Joining the company's existing New England campus is a new 160,000 square-foot facility, purpose-built for cGMP pallet storage space at 15°C to 30°C.
"As the preferred provider of cGMP...
News
Incog Biopharma Completes Construction of Cleanrooms, On Track To Manufacture Injectable Drug Products in Q3 2022
INCOG BioPharma Services an Indiana-based contract development and manufacturing organization (CDMO) reached another major milestone in its facility by completing the construction of its cleanroom production area within the new 90,000ft2 biopharma manufacturing site.
The fill-finish organization will be a...
News
Charles River Laboratories Acquires Explora BioLabs
Charles River Laboratories International, Inc. announced that it has acquired Explora BioLabs Holdings, Inc., a premier provider of contract vivarium research services.
Based in San Diego, California, Explora BioLabs offers contract vivarium operation services, providing biopharmaceutical clients with turnkey in...
News
Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced the acquisition from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC...
News
Stanley Capital-backed portfolio company DSS acquires MyMeds&Me
Stanley Capital Partners LLP (SCP), the European and US-focused mid-market private equity firm, today announced the acquisition of MyMeds&Me Limited (MMM) by its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS). DSS is a leading global provider of...
News
ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, announces significant growth in the global footprint of its LifeSphere Clinical software, following the customer wins of two prominent...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read